Making Every Component Count: Using the Shapley Value To Improve Win Ratio Analysis
ISEF · 2025 Mathematics Fourth Award
Overview
Clinical trials often utilize composite endpoints to provide a comprehensive evaluation of a treatment’s effects by combining multiple related outcomes into a single measure. While traditional methods, such as time-to-first-event analysis, are widely used, they face limitations, including equal weighting of components, disproportionate influence of non-fatal events, and neglect of recurrent outcomes. The win ratio has emerged as an alternative, prioritizing outcomes by clinical importance and offering greater flexibility. However, it provides limited insight into the contributions of individual components to the overall treatment effect. To address this gap, we develop the SEWRA (Shapley-Enhanced Win Ratio Analysis) algorithm, which integrates the Shapley value, a concept from cooperative game theory, into win ratio analysis. SEWRA fairly allocates the total treatment effect across the components of a composite endpoint, reflecting their relative contributions within the context of the overall win ratio. This approach enhances the interpretability of the win ratio and provides a deeper understanding of the treatment’s impact on individual outcomes. Through simulations and case studies, we demonstrate how SEWRA offers a nuanced framework for analyzing composite endpoints, complementing existing methodologies and addressing their limitations. Our work aims to advance the analytical tools available for clinical trial data, promoting more informed decision-making and improved patient outcomes.
Awards (1)
- Fourth Award of $600 $600
Competition history
- ISEF 2025
Resources
Related projects
JSHS · 2025
Experience-based neural tradeoffs in perceptual sampling vs. predictive processing in the visual domain
ISEF · 2016
Predictive Modeling of Optimal Cancer Therapies
CSEF · 2026
Predicting Synergistic Cancer Drug Combinations Using a Disease-Agnostic Machine Learning Approach
ISEF · 2026
From SMILES to Synergy: Biologically-Enriched Drug Screening for Synergistic Combination Therapy in Tamoxifen Resistant ER+ Breast Cancer
ISEF · 2014
Rational Discovery and Optimization of Synergistic Chemotherapy Combinations: A Novel Framework Integrating Gene Perturbation Analysis and Machine Learning Algorithms
CSEF · 2015
The 99¢ Clinical Trial: Accelerating Trials in Software for ErbB2 Pathways and Lapatinib on Metastatic Breast Cancer
CSEF · 2014
Indium: Using Novel Machine Learning Algorithms to Develop a Nondisease-specific Personalized Medicine Engine
CSEF · 2015
A Systems Biology Approach to Optimize Prediction of Efficacy of Pathway Targeted Therapies in Cancer
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair